Cite
HARVARD Citation
Sivapalasingam, S. et al. (2018). Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study. Lancet infectious diseases. 18 (8), pp. 884-893. [Online].